Aurobindo Pharma arm gets USFDA nod for Plerixafor injection
![](https://etimg.etb2bimg.com/thumb/msid-102102668,imgsize-28900,width-1200,height=765,overlay-ethealth/pharma/aurobindo-pharma-arm-gets-usfda-nod-for-plerixafor-injection.jpg)
Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM), the company said.
Source – ETHealth World